In a recent 2012 issue of the Archives of Internal Medicine, Culver and his associates at University of Massachusetts reported an association between use of statins and increased risk of developing diabetes mellitus in menopausal women.
These statin drugs have been associated with deterioration of memory, weight gain, thyroid abnormalities, depression and now diabetes, specifically over 50 % increase incidence in diabetes in menopausal women.
I see hundreds of menopausal women treated inappropriately with stains without clear cut indications for prescribing them.
This group of women is now struggling with increased incidences of diabetes and the associated devastating effects of diabetes.
Since there have been no reliable studies to support the use of statins in primary prevention of heart disease in women, I actively try to discontinue the statin drugs and routinely see improvement in energy levels, memory, joint pain, and diabetes.
In a 2011 study out of Scotland, the main investigators made the statement: “The cardiovascular benefits of statin therapy clearly outweigh the risk of developing diabetes.”
Unfortunately they don’t.
In fact, the Cochrane Collaboration team recently reviewed all the statin literature and recommended that statins should not be used in Primary Prevention.
Did you hear much about that?
Their damning new analysis found that statins don’t make a drop of difference for 99.9 percent of all low-risk customers conned and coerced into taking them.
Surprisingly, women who are not obese and in good condition are the ones most likely to get statin induced diabetes. Of course, with the new stain-induced diabetes, and elevated sugar levels, the increased abdominal fat and weight gain is a guarantee.
The only benefit to statins is to line the pockets of statin manufacturers who made 36 billion dollars last year (188 billion globally). So now thousands, probably millions of women are taking statins which cause diabetes and they are taking it for absolutely no reason.
So many patients are being told that with elevated cholesterol levels, they have to take a statin or they will have a stroke or heart attack.
And that is an absolute lie.
The data does not support that.
Based on the data in the recent study by Dr. Culver, 498 postmenopausal women would need to take statin drugs before triggering one case of diabetes; whereas, in the ASCOT statin trial that examined the benefits of statins for primary prevention, 667 women would need to take a statin straight for 3 years to protect just one from a heart attack.
Creating diabetes, thyroid disease, limiting joint and muscle pains, and memory changes in 667 women to only really have any benefit for one of those women doesn’t seem like very good odds. From those statistics, it seems quite clear that there is no benefit to using statins in women with elevated cholesterol levels. And a large group of physicians re-examining the statin data this year (Cochrane Collaboration) agree that there is no benefit to using statins in women for primary prevention.
Learn more about preventative medicine at Andlos.
Robert G Carlson, MD, FACS